Page last updated: 2024-10-29

irsogladine and Hepatitis C, Chronic

irsogladine has been researched along with Hepatitis C, Chronic in 1 studies

irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt

Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.

Research Excerpts

ExcerptRelevanceReference
"Aphthous stomatitis is one of the adverse effects associated with interferon (IFN) that forces dose reduction of IFN and there is no established therapy."1.39Irsogladine maleate for the treatment of recurrent aphthous stomatitis in hepatitis C virus patients on pegylated-interferon and ribavirin: a pilot study. ( Arisawa, T; George, J; Hayashi, N; Saito, T; Shiroeda, H; Toshikuni, N; Tsuchishima, M; Tsutsumi, M, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, N1
George, J1
Shiroeda, H1
Saito, T1
Toshikuni, N1
Tsuchishima, M1
Arisawa, T1
Tsutsumi, M1

Other Studies

1 other study available for irsogladine and Hepatitis C, Chronic

ArticleYear
Irsogladine maleate for the treatment of recurrent aphthous stomatitis in hepatitis C virus patients on pegylated-interferon and ribavirin: a pilot study.
    Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:6

    Topics: Anti-Ulcer Agents; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Inter

2013